Joe Murphy

Absorption, Metabolism, and Excretion of Oral 14C Radiolabeled Ibrutinib: An Open-Label, Phase I, Single-Dose Study in Healthy Men

Ellen Scheers, Laurent Leclercq, Jan de Jong et al. · Drug Metabolism and Disposition · 2014 · 137 citations

Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis

Clapton Dias, Kenneth Todd Moore, Joe Murphy et al. · American Journal of Nephrology · 2016 · 129 citations · Full text

Effect of <scp>CYP</scp>3A perpetrators on ibrutinib exposure in healthy participants

Jan de Jong, Donna Skee, Joe Murphy et al. · Pharmacology Research & Perspectives · 2015 · 98 citations · Full text

The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia

Jan de Jong, Juthamas Sukbuntherng, Donna Skee et al. · Cancer Chemotherapy and Pharmacology · 2015 · 73 citations · Full text

Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants

Damayanthi Devineni, Nicole Vaccaro, Joe Murphy et al. · International Journal of Clinical Pharmacology and Therapeutics · 2014 · 45 citations · Full text